Skip to content
AnalystLens

Somnigroup International Quarterly Report for Q2 Ended Jun 30, 2025

Filing Date
Filed August 8, 2025
Period End
June 30, 2025
Security
SGI
One revenue dollarkept$0.05
In the record · 2016–202610-K1110-Q328-K220

SGI filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 220 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Mar ’18Mar ’18
  2. Material agreement8-K · May ’20May ’20
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Deal closed8-K · Aug ’26Aug ’26

Summary

Summary of the 10-Q filed August 8, 2025. Cited figures are marked; the original filing is the authoritative source.

Somnigroup International Inc. reported a sharp expansion in its second-quarter 2025 results following the February 5, 2025 acquisition of Mattress Firm.

Net sales for the three months ended June 30, 2025 were $1,880.8 milliona, up 52.5% from $1,233.6 million, with the Mattress Firm segment contributing $948.8 million. Operating income rose only modestly to $179.9 million from $173.3 million, while net income attributable to the company fell to $99.0 million from $106.1 million and diluted EPS was $0.47 versus $0.60. The filing attributes the rise in interest expense, which increased 117.1% to $72.5 million, to higher average variable-rate debt.

For the six months, the company reported net income attributable to Somnigroup of $65.9 millionb, down from $182.4 million, and a loss on the Mattress Firm pre-acquisition period included a one-time $340.5 million stock-based compensation charge. The balance sheet changed substantially. Total assets rose to $11,376.2 million from $5,980.4 million at December 31, 2024, driven by goodwill of $4,585.2 million, intangible assets of $2,373.2 million, and higher operating lease right-of-use assets.

Total debt increased to $4,951.6 millionc from $3,844.5 million, and the company reported a working capital deficit of $294.5 million. Management stated a consolidated indebtedness less netted cash to adjusted EBITDA ratio of 3.56 times, within the 5.00 times covenant limit, and a target leverage range of 2.0 to 3.0 times in 2026.

Adjusted diluted EPS for the quarter was $0.53d, down from $0.63, and adjusted operating income rose to $224.4 million from $180.6 million. The company also disclosed a $13.9 million loss on the May 1, 2025 divestiture of 73 Mattress Firm retail locations and Sleep Outfitters, and it expects 2025 capital expenditures of approximately $200 million.

Key Highlights

  1. Net sales rose 52.5% to $1,880.8 million, driven by $948.8 million of Mattress Firm sales for the quarter.
  2. Operating income increased to $179.9 million from $173.3 million, while operating margin declined to 9.6% from 14.0%.
  3. Net income attributable to Somnigroup fell 6.7% to $99.0 million, and diluted EPS was $0.47 versus $0.60; adjusted EPS was $0.53 versus $0.63.
  4. Interest expense, net, increased 117.1% to $72.5 million, reflecting higher average variable-rate debt.
  5. Total assets increased to $11,376.2 million from $5,980.4 million, including goodwill of $4,585.2 million following the Mattress Firm Acquisition.
  6. Total debt rose to $4,951.6 million, with a consolidated indebtedness less netted cash to adjusted EBITDA ratio of 3.56 times versus a 5.00 times covenant limit.
  7. The company recorded a $13.9 million loss on the divestiture of 73 Mattress Firm locations and Sleep Outfitters, and declared a $0.15 per share dividend for the third quarter of 2025.

Follow one dollar

Of each $1.00 of revenue in Q2 FY2025, Somnigroup International kept $0.05.

  1. Revenue$1.88B100.0%
  2. Cost of revenue−$1.05B56.0%
  3. Gross profit$827.2M44.0%
  4. Operating costs−$647.3M34.4%
  5. Operating income$179.9M9.6%
  6. Interest, other & tax−$80.9M4.3%
  7. Net income$99.0M5.3%
Computed from 10-QQ2 FY2025filed August 8, 2025Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q2 FY2025 against Q2 FY2024

Line itemQ2 FY2025Q2 FY2024Change
Revenue$1.88B$1.23B+52.5%
Cost of Revenue$1.05B$716.00M+47.2%
Gross Profit$827.20M$517.60M+59.8%
Operating Income$179.90M$173.30M+3.8%
Net Income$99.00M$106.10M−6.7%
EPS (Basic)$0.47$0.61−23.0%
EPS (Diluted)$0.47$0.60−21.7%
Shares Outstanding (Basic)209.20M173.70M+20.4%
Shares Outstanding (Diluted)212.40M178.00M+19.3%

Frequently Asked Questions

  1. Why did net sales grow so much while net income declined?

    Net sales increased 52.5% to $1,880.8 million mainly because the filing includes $948.8 million of Mattress Firm sales for the quarter. Net income attributable to Somnigroup declined to $99.0 million from $106.1 million, as higher selling and marketing expenses ($460.5 million versus $239.6 million), general and administrative expenses, and interest expense ($72.5 million versus $33.4 million) offset the gain in gross profit. The filing also notes business combination charges of $17.6 million and the $13.9 million loss on disposal.

  2. How did the Mattress Firm Acquisition change the company's financial position?

    The acquisition, completed February 5, 2025, had an aggregate purchase price of approximately $5.1 billion net of cash acquired, consisting of $3.1 billion in cash and about 34.2 million common shares. Goodwill rose to $4,585.2 million from $1,066.7 million, and trade name and other intangible assets rose to $2,373.2 million from $700.5 million. The company also borrowed $625.0 million under its Delayed Draw Term A Loan and $679.5 million under its revolver.

  3. What is the company's leverage and liquidity position?

    As of June 30, 2025, total debt was $4,951.6 million and cash and cash equivalents were $98.1 million. Total liquidity was $805.8 million, including $707.7 million available under the 2023 Credit Agreement revolver. The company reported a working capital deficit of $294.5 million, which it expects to continue, and stated it was in compliance with all financial covenants.

  4. What did management say about the outlook and capital allocation?

    Management expects its target leverage ratio of 2.0 to 3.0 times to be reached in 2026 and expects to focus primarily on debt repayment in 2025, with only strategic share repurchases. It expects 2025 capital expenditures of approximately $200 million, including $25 million to refresh Mattress Firm stores, and total cash interest payments of approximately $260 million to $265 million in 2025. It also said it does not expect the divestiture to have a material impact on results for the twelve months ending December 31, 2025.

  5. Did the company repurchase shares during the period?

    No shares were repurchased under the publicly announced share repurchase program during the three or six months ended June 30, 2025, leaving $774.5 million of authorization remaining. However, the company acquired 2.1 million shares for $132.4 million during the six months to satisfy tax withholding obligations upon vesting of equity awards.